PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:22 AM ET

Sponsor Check › Person

RB
No photo found yet (own website and image search run after this page is viewed)

Ross Barrett

Named as an officer, director or promoter on SEC Form D filings · LA, MA, GA, CO, TX · Apr 13, 2009 → May 22, 2026

11deals (issuers)
$98.6Mreported sold
196investors
34Form D filings
2009–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 3:01 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Ross Barrett is listed as an executive officer and director on 34 SEC Form D filings by 11 issuers between Apr 2009 and May 2026. Largest by amount reported sold: Cancer Focus Fund, LP (Houston, TX — pooled investment fund — 2019; $49.7M reported sold to 19 investors), Cancer Focus Fund II, LP (Shreveport, LA — pooled investment fund — 2025–2026; $22.6M reported sold to 5 investors), Esperance Pharmaceuticals, Inc (Houston, TX — biotechnology — 2010–2019; $9M reported sold to 10 investors), EMBERA NEUROTHERAPEUTICS, INC. (Sudbury, MA — pharmaceuticals — 2009–2019; $6.13M reported sold to 70 investors), SOUTHEAST VENTURE HOLDINGS, LLC (Sarasota, FL — agriculture — 2016; $2.31M reported sold to 7 investors) and 6 more (all listed below).

What this means That is a lot of deals — 11 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $98.6M sold in total.

Listed alongside Joseph Lovett (20 shared filings), Robert B. Linke (9 shared filings), Franz Hefti (5 shared filings), Nicholas E. Goeders (5 shared filings), Dale Pfost (4 shared filings) and 35 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ross. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 5 bankruptcy cases matching the name listed in Key records below.

What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 34 public filings for Ross Barrett and found 12 differences, 4 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Ross Barrett has not run yet — it is #2,735 of 14,300 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 3:01 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Ross Barrett..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

5 cases: 5 closed (disposition not in docket feed)

Ross W. Barrett and Gary W. Max closed
United States Bankruptcy Court, D. Maine · No. 20-10024 · Filed Jan 17, 2020 · Closed May 4, 2020
Role of Ross W. Barrett and Gary W. Max: Debtor · Outcome: Case closed 2020-05-04 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in ME (not a filing state)
Ross S. Barrett closed
United States Bankruptcy Court, D. Connecticut · No. 09-20661 · Filed Mar 20, 2009 · Closed Jul 14, 2009
Role of Ross S. Barrett: Debtor · Outcome: Case closed 2009-07-14 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in CT (not a filing state)
Ross W. Barrett closed
United States Bankruptcy Court, D. New Jersey · No. 01-17252 · Filed Jul 16, 2001 · Closed Oct 20, 2003
Role of Ross W. Barrett: Debtor · Outcome: Case closed 2003-10-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in NJ (not a filing state)
ROSS BARRETT and HEDVIG A. BARRETT closed
United States Bankruptcy Court, D. Nevada · No. 98-23724 · Filed May 1, 1998 · Closed Dec 28, 2005
Role of ROSS BARRETT and HEDVIG A. BARRETT: Debtor · Outcome: Case closed 2005-12-28 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in NV (not a filing state)
Ross S. Barrett closed
United States Bankruptcy Court, D. Connecticut · No. 93-23836 · Filed Oct 7, 1993 · Closed Aug 17, 1998
Role of Ross S. Barrett: Debtor · Outcome: Case closed 1998-08-17 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in CT (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 3:01 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

12 differences found between the filings for Ross Barrett — 4 worth asking about (compared 34 filings on Oct 24, 2026)

Worth asking · May 3, 2010

Amount sold went down between filings — Esperance Pharmaceuticals, Inc

The May 3, 2010 filing says $9,000,000 sold; the May 3, 2010 Form D/A says $3,700,245 sold — $5,299,755 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D/A (earlier) · May 3, 2010 ↗Form D/A (later) · May 3, 2010 ↗Esperance Pharmaceuticals, Inc — PartnerFacts page ↗
Sources
Worth asking · May 28, 2009

Amount sold went down between filings — EMBERA NEUROTHERAPEUTICS, INC.

The May 28, 2009 filing says $300,000 sold; the May 28, 2009 Form D says $100,000 sold — $200,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · May 28, 2009 ↗Form D (later) · May 28, 2009 ↗EMBERA NEUROTHERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Worth asking · May 28, 2009

Investor count went down between filings — EMBERA NEUROTHERAPEUTICS, INC.

The May 28, 2009 filing reports 5 investors; the May 28, 2009 Form D reports 1 investor.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · May 28, 2009 ↗Form D (later) · May 28, 2009 ↗EMBERA NEUROTHERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Worth asking · Oct 26, 2012 – Jan 14, 2025

7 Form Ds were filed more than 15 days after the first sale

Form D filed 1,078 days after the first sale — A28 Therapeutics, Inc. · Form D filed 441 days after the first sale — CALOSYN PHARMA, INC. · Form D filed 135 days after the first sale — NuPotential, Inc. · Form D filed 95 days after the first sale — NuPotential, Inc. · Form D filed 26 days after the first sale — Congress Avenue Equity Armor, LP · and 2 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Jan 14, 2025 ↗A28 Therapeutics, Inc. — PartnerFacts page ↗Form D · Mar 7, 2024 ↗CALOSYN PHARMA, INC. — PartnerFacts page ↗
Sources
Note · Feb 29, 2012 – Mar 7, 2024

Ross Barrett's role changed at CALOSYN PHARMA, INC.: director → executive officer, director

The Feb 29, 2012 filing lists Ross Barrett as director; the Mar 7, 2024 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Feb 29, 2012 ↗Form D · Mar 7, 2024 ↗Ross Barrett — PartnerFacts page ↗CALOSYN PHARMA, INC. — PartnerFacts page ↗
Sources
Note · Apr 13, 2009 – Sep 29, 2015

7 offerings changed their target amount between filings

Offering amount changed between filings — EMBERA NEUROTHERAPEUTICS, INC. · Offering amount changed between filings — MicroBiome Therapeutics, LLC · Offering amount lowered between filings — Esperance Pharmaceuticals, Inc · Offering amount changed between filings — CALOSYN PHARMA, INC. · Offering amount changed between filings — EMBERA NEUROTHERAPEUTICS, INC. · and 2 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Jan 23, 2015 ↗Form D/A (later) · Sep 29, 2015 ↗EMBERA NEUROTHERAPEUTICS, INC. — PartnerFacts page ↗Form D (earlier) · Oct 23, 2014 ↗
Sources
Note · Oct 18, 2006 – Mar 7, 2024

17 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — CALOSYN PHARMA, INC. (latest filing Mar 7, 2024) · No amendment in the last 12 months on an offering that may still be open — Lagniappe Labs, LLC (latest filing Jun 15, 2020) · No amendment in the last 12 months on an offering that may still be open — EMBERA NEUROTHERAPEUTICS, INC. (latest filing Dec 30, 2019) · No amendment in the last 12 months on an offering that may still be open — Cancer Focus Fund, LP (latest filing Dec 24, 2019) · No amendment in the last 12 months on an offering that may still be open — Congress Avenue Equity Armor, LP (latest filing Jun 27, 2019) · and 12 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Mar 7, 2024 ↗CALOSYN PHARMA, INC. — PartnerFacts page ↗Form D · Jun 15, 2020 ↗Lagniappe Labs, LLC — PartnerFacts page ↗
Sources
Note · Apr 13, 2009 – May 28, 2009

Ross Barrett is written 2 different ways on the filings

listed as "Ross Barrett" on 22 filings (from Apr 13, 2009), and "Ross P. Barrett" on 12 filings (from May 28, 2009).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Apr 13, 2009 ↗Form D · May 28, 2009 ↗Ross Barrett — PartnerFacts page ↗
Sources
Note · May 2, 2012 – Dec 10, 2013

Industry group changed between filings — MicroBiome Therapeutics, LLC

"Biotechnology" (May 2, 2012); then "Other Health Care" (Dec 10, 2013 to Jun 23, 2015).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · May 2, 2012 ↗Form D · Dec 10, 2013 ↗MicroBiome Therapeutics, LLC — PartnerFacts page ↗
Sources
Note · Mar 10, 2010 – Mar 7, 2024

6 address changes between filings

Address moved from Atlanta, GA to Shreveport, LA — CALOSYN PHARMA, INC. · Address moved from Baton Rouge, LA to Houston, TX — Esperance Pharmaceuticals, Inc · Address moved from Broomfield, CO to New Orleans, LA — MicroBiome Therapeutics, LLC · Address moved from New Orleans, LA to Broomfield, CO — MicroBiome Therapeutics, LLC · Address moved from Baton Rouge, LA to Atlanta, GA — CALOSYN PHARMA, INC. · and 1 more

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Feb 29, 2012 ↗Form D · Mar 7, 2024 ↗CALOSYN PHARMA, INC. — PartnerFacts page ↗Form D · Jun 9, 2011 ↗
Sources
Note · Apr 13, 2009 – May 22, 2026

Ross Barrett is listed with 5 different address states: LA, MA, GA, CO, TX

LA on 25 filings (Apr 13, 2009 to May 22, 2026); MA on 5 filings (Aug 16, 2011 to Dec 30, 2019); GA on 1 filing (Feb 29, 2012); CO on 2 filings (Dec 10, 2013 to Oct 23, 2014); TX on 1 filing (Jul 12, 2019).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Apr 13, 2009 ↗Form D · Aug 16, 2011 ↗Form D · Feb 29, 2012 ↗Form D · Dec 10, 2013 ↗
Sources
Note · May 3, 2010 – Jul 12, 2019

Reported revenue range changed between filings — Esperance Pharmaceuticals, Inc

"No Revenues" (May 3, 2010); then "Decline to Disclose" (Jul 12, 2019).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D/A · May 3, 2010 ↗Form D · Jul 12, 2019 ↗Esperance Pharmaceuticals, Inc — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 22 offerings reports sales commissions totalling $3,000; 0 report finder's fees; 3 report proceeds to related persons totalling $258,410. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
May 22, 2026 D/A
Cancer Focus Fund II, LP
File 021-547107
$0$0$0None listed on this filingEDGAR ↗
Jan 14, 2025 D
A28 Therapeutics, Inc.
File 021-535069
$0$0$0None listed on this filingEDGAR ↗
Mar 7, 2024 D
CALOSYN PHARMA, INC.
File 021-507011
$0$0$144,000 (est.)
$144,000 will go towards compensating the President and Chief Executive Officer.
None listed on this filingEDGAR ↗
Jun 15, 2020 D
Lagniappe Labs, LLC
File 021-368961
$0$0$0None listed on this filingEDGAR ↗
Dec 30, 2019 D/A
EMBERA NEUROTHERAPEUTICS, INC.
File 021-350179
$3,000$0$0Witherspoon Partners BrokerCheck CRD 226591 ↗EDGAR ↗
Dec 24, 2019 D
Cancer Focus Fund, LP
File 021-356366
$0$0$0None listed on this filingEDGAR ↗
Jul 12, 2019 D
Esperance Pharmaceuticals, Inc
File 021-344116
$0$0$100,000 (est.)None listed on this filingEDGAR ↗
Jun 27, 2019 D/A
Congress Avenue Equity Armor, LP
File 021-289508
$0$0$0Thornhill Securities, Inc. BrokerCheck CRD 22333 ↗EDGAR ↗
Nov 7, 2017 D
Lagniappe Labs, LLC
File 021-298243
$0$0$0None listed on this filingEDGAR ↗
Feb 25, 2016 D
SOUTHEAST VENTURE HOLDINGS, LLC
File 021-258127
$0$0$14,410
Out of initial closing proceeds, Mr. Bartner was paid the amount above which represented interest accrued on a prior promissory note, the principal of which he agreed to roll-forward under the new Promissory Note Purchase Agreement & Credit Facility.
None listed on this filingEDGAR ↗
Sep 29, 2015 D/A
EMBERA NEUROTHERAPEUTICS, INC.
File 021-232778
$0$0$0None listed on this filingEDGAR ↗
Jun 23, 2015 D/A
MicroBiome Therapeutics, LLC
File 021-227005
$0$0$0None listed on this filingEDGAR ↗
Mar 5, 2014 D
NuPotential, Inc.
File 021-212975
$0$0$0None listed on this filingEDGAR ↗
Dec 10, 2013 D
MicroBiome Therapeutics, LLC
File 021-207743
$0$0$0None listed on this filingEDGAR ↗
Mar 7, 2013 D/A
NuPotential, Inc.
File 021-190945
$0$0$0None listed on this filingEDGAR ↗
May 2, 2012 D
MicroBiome Therapeutics, LLC
File 021-177597
$0$0$0None listed on this filingEDGAR ↗
Feb 29, 2012 D
CALOSYN PHARMA, INC.
File 021-174155
$0$0$0None listed on this filingEDGAR ↗
Aug 16, 2011 D
EMBERA NEUROTHERAPEUTICS, INC.
File 021-164546
$0$0$0None listed on this filingEDGAR ↗
Jun 9, 2011 D
Esperance Pharmaceuticals, Inc
File 021-160997
$0$0$0None listed on this filingEDGAR ↗
May 3, 2010 D/A
Esperance Pharmaceuticals, Inc
File 021-124766
$0$0$0None listed on this filingEDGAR ↗
Apr 13, 2010 D/A
CALOSYN PHARMA, INC.
File 021-115888
$0$0$0 (est.)
Proceeds from the offering will be used for general working capital.
None listed on this filingEDGAR ↗
Mar 10, 2010 D/A
EMBERA NEUROTHERAPEUTICS, INC.
File 021-99589
$0$0$0
Proceeds will be used for general working capital.
None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 11

Every issuer that named Ross Barrett on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

CF
Pooled Investment Fund

Cancer Focus Fund II, LP

Shreveport, LA · May 23, 2025 → May 22, 2026 · 2 filings
  • May 22, 2026 · D/A · $22,556,962 sold of $250,000,000 · 5 investors · min. No minimum reported · role: Director, Executive Officer (Managing Member of the General Partner of the Issuer) EDGAR ↗
  • May 23, 2025 · D · $0 sold of $250,000,000 · 1 investors · min. No minimum reported · role: Director, Executive Officer (Managing Member of the General Partner of the Issuer) EDGAR ↗

Raised $22.6M from 5 investors (9% of the $250M target) as of the latest filing. Ross is listed as director, executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(c) (8,096 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Other Technology

A28 Therapeutics, Inc.

La Jolla, CA · Jan 14, 2025
  • Jan 14, 2025 · D · $1,900,000 sold of $1,900,000 · 26 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $1.9M from 26 investors (100% of the $1.9M target) as of the latest filing. Ross is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Biotechnology

CALOSYN PHARMA, INC.

Shreveport, LA · Apr 13, 2009 → Mar 7, 2024 · 4 filings
  • Mar 7, 2024 · D · $750,000 sold of $2,000,000 · 7 investors · min. No minimum reported · role: Executive Officer, Director (Secretary) EDGAR ↗
  • Feb 29, 2012 · D · $309,685 sold of $2,100,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 13, 2010 · D/A · $1,863,392 sold of $3,265,653 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 13, 2009 · D · $400,000 sold of $400,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $1.86M from 7 investors (93% of the $2M target) as of the latest filing. Ross is listed as executive officer, director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

LL
Other Technology

Lagniappe Labs, LLC

Shreveport, LA · Nov 7, 2017 → Jun 15, 2020 · 2 filings
  • Jun 15, 2020 · D · $534,056 sold of $800,000 · 13 investors · min. No minimum reported · role: Executive Officer, Director (LLC Manager) EDGAR ↗
  • Nov 7, 2017 · D · $1,652,301 sold of $2,402,301 · 12 investors · min. $100,000 · role: Executive Officer, Director EDGAR ↗

Raised $1.65M from 13 investors (100% of the $800K target) as of the latest filing. Ross is listed as executive officer, director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

EN
Pharmaceuticals

EMBERA NEUROTHERAPEUTICS, INC.

Sudbury, MA · May 28, 2009 → Dec 30, 2019 · 9 filings
  • Dec 30, 2019 · D/A · $6,128,235 sold of $8,282,455 · 70 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 2, 2019 · D · $6,128,235 sold of $8,282,455 · 70 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 29, 2015 · D/A · $4,511,399 sold of $6,641,944 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 23, 2015 · D · $2,345,289 sold of $4,488,523 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 16, 2011 · D · $3,505,644 sold of $4,505,800 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 10, 2010 · D/A · $490,000 sold of $880,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 5, 2009 · D · $100,000 sold of $300,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 28, 2009 · D · $100,000 sold of $100,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 28, 2009 · D · $300,000 sold of $500,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $6.13M from 70 investors (74% of the $8.28M target) as of the latest filing. Ross is listed as director on 9 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CF
Pooled Investment Fund

Cancer Focus Fund, LP

Houston, TX · Dec 24, 2019
  • Dec 24, 2019 · D · $49,700,000 sold of $75,000,000 · 19 investors · min. $1,000,000 · role: Executive Officer (President, CEO and CFO of Focus Fund GP, LLC, the GP of the Issuer.) EDGAR ↗

Raised $49.7M from 19 investors (66% of the $75M target) as of the latest filing. Ross is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

EP
Biotechnology

Esperance Pharmaceuticals, Inc

Houston, TX · May 3, 2010 → Jul 12, 2019 · 4 filings
  • Jul 12, 2019 · D · $1,000,000 sold of $1,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 9, 2011 · D · $5,733,626 sold of $7,500,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 3, 2010 · D/A · $9,000,000 sold of $9,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 3, 2010 · D/A · $3,700,245 sold of $5,750,001 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $9M from 10 investors (100% of the $1M target) as of the latest filing. Ross is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CA
Pooled Investment Fund

Congress Avenue Equity Armor, LP

Bossier City, LA · Jun 27, 2017 → Jun 27, 2019 · 3 filings
  • Jun 27, 2019 · D/A · $1,849,568 sold of Indefinite · 7 investors · min. $1,000,000 · role: Director (Mr. Barrett is the managing member of Congress Avenue Holdings, LLC, the general partner of Congress Avenue GP, LP, the general partner of the issuer.) EDGAR ↗
  • Jun 28, 2018 · D/A · $1,600,000 sold of Indefinite · 5 investors · min. $1,000,000 · role: Director (Mr. Barrett is the managing member of Congress Avenue Holdings, LLC, the general partner of Congress Avenue GP, LP, the general partner of the issuer.) EDGAR ↗
  • Jun 27, 2017 · D · $750,000 sold of Indefinite · 3 investors · min. $1,000,000 · role: Director (Mr. Barrett is the managing member of Congress Avenue Holdings, LLC, the general partner of Congress Avenue GP, LP, the general partner of the issuer.) EDGAR ↗

Raised $1.85M from 7 investors as of the latest filing. Ross is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SV
Agriculture

SOUTHEAST VENTURE HOLDINGS, LLC

Sarasota, FL · Feb 25, 2016
  • Feb 25, 2016 · D · $2,310,000 sold of $7,000,000 · 7 investors · min. No minimum reported · role: Director (Member and Director of the Manager) EDGAR ↗

Raised $2.31M from 7 investors (33% of the $7M target) as of the latest filing. Ross is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Agriculture / 506(b) (448 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MT
Other Health Care

MicroBiome Therapeutics, LLC

New Orleans, LA · May 2, 2012 → Jun 23, 2015 · 4 filings
  • Jun 23, 2015 · D/A · $743,445 sold of $1,800,000 · 27 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 23, 2014 · D · $30,000 sold of $600,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 10, 2013 · D · $1,265,131 sold of $3,000,000 · 19 investors · min. $20,000 · role: Director EDGAR ↗
  • May 2, 2012 · D · $1,109,985 sold of $1,500,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $1.27M from 27 investors (70% of the $1.8M target) as of the latest filing. Ross is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

N
Pharmaceuticals

NuPotential, Inc.

Baton Rouge, LA · Jan 29, 2013 → Mar 5, 2014 · 3 filings
  • Mar 5, 2014 · D · $375,000 sold of $375,000 · 5 investors · min. $25,000 · role: Director EDGAR ↗
  • Mar 7, 2013 · D/A · $350,000 sold of $350,000 · 2 investors · min. $35,000 · role: Director EDGAR ↗
  • Jan 29, 2013 · D · $210,000 sold of $350,000 · 2 investors · min. $35,000 · role: Director EDGAR ↗

Raised $375K from 5 investors (100% of the $375K target) as of the latest filing. Ross is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Ross 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

CA
Management entity

Congress Avenue Holdings, LLC

Promoter · 3 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

CA
Management entity

Congress Avenue GP, LP

Promoter · 3 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

FF
Management entity

Focus Fund GP II, LLC

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Lovett

Director, Executive Officer · 20 shared filings (4 issuers) · also on 2 other issuers

Joseph Lovett is on 6 issuers in total — a repeat sponsor. Their page lists every one.

RL
No photo found yet (own website and image search run after this page is viewed)
Person

Robert B. Linke

Executive Officer, Director · 9 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

NG
No photo found yet (own website and image search run after this page is viewed)
Person

Nicholas E. Goeders

Director, Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

FH
No photo found yet (own website and image search run after this page is viewed)
Person

Franz Hefti

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ross Barrett. Their page shows their other deals.

RB
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Babb

Executive Officer, Director · 4 shared filings (2 issuers) · also on 4 other issuers

Richard Babb is on 6 issuers in total — a repeat sponsor. Their page lists every one.

DW
No photo found yet (own website and image search run after this page is viewed)
Person

David Waddell

Director · 4 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

HA
No photo found yet (own website and image search run after this page is viewed)
Person

Hector Alila

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

JE
No photo found yet (own website and image search run after this page is viewed)
Person

John Elstrott

Director, Promoter · 4 shared filings (1 issuer) · also on 5 other issuers

John Elstrott is on 6 issuers in total — a repeat sponsor. Their page lists every one.

DP
No photo found yet (own website and image search run after this page is viewed)
Person

Dale Pfost

Director, Promoter, Executive Officer · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Ross Barrett. Their page shows their other deals.

RM
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Montgomery

Director · 4 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

CS
No photo found yet (own website and image search run after this page is viewed)
Person

Chad Souvignier

Director · 3 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Snowdy

Director, Executive Officer · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Ross Barrett. Their page shows their other deals.

KE
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth J. Eilertsen

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

Joan P. Neuscheler

Executive Officer, Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ross Barrett. Their page shows their other deals.

CO
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Oehler

Director · 3 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

PC
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Cordes

Director · 3 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Heiman

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

John Beaird

Director · 3 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

SO
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Orndorff

Executive Officer, Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Ross Barrett. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Don Marvin

Director · 2 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Crawford

Director · 2 shared filings (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

Dean P. Stull

Executive Officer, Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Ross Barrett. Their page shows their other deals.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Martin Becker

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Mike Sherman

Director · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Donald Marvin

Director · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

RB
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Bartner

Director · 1 shared filing (1 issuer) · also on 7 other issuers

Robert Bartner is on 8 issuers in total — a repeat sponsor. Their page lists every one.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher G Cogan

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Ross Barrett. Their page shows their other deals.

MV
No photo found yet (own website and image search run after this page is viewed)
Person

Management, LLC Southeast Venture

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

KC
No photo found yet (own website and image search run after this page is viewed)
Person

Kay D. Carter

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

AD
No photo found yet (own website and image search run after this page is viewed)
Person

Ariane M. Dart

Director · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

RT
No photo found yet (own website and image search run after this page is viewed)
Person

Rod Taylor

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Brad Swearingen

Director · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

PH
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Hoang

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Ross Barrett. Their page shows their other deals.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Sonia Deggs

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

CL
No photo found yet (own website and image search run after this page is viewed)
Person

Carola Leuschner

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

WG
No photo found yet (own website and image search run after this page is viewed)
Person

William R. Grimes

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

SL
No photo found yet (own website and image search run after this page is viewed)
Person

STANLEY LEWIS

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Ross Barrett. Their page shows their other deals.

The team behind the deals

Same business address

2 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 11 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

3 Regulation Crowdfunding filings — tap to see each filing
SourceFiledFormIssuerAmount offered (as reported)Amount sold (as reported)Matched on
EDGAR ↗Mar 2, 2026
File 020-36429
Regulation Crowdfunding progress update (Form C-U)
Progress update filed · deadline Feb 27, 2026
CALOSYN PHARMA, INC.
SHREVEPORT, LA
$20,000 target · $1,235,000 maximum
via StartEngine Primary, LLC
Not reported on this formsigner name on this filing (Ross Pryor Barrett) + listed as a related person on Form D filings of the same issuer (CIK 1429819) · 85%
EDGAR ↗Dec 19, 2025
File 020-36429
Regulation Crowdfunding offering — amendment (Form C/A)
Amendment filed · deadline Feb 27, 2026
Calosyn Pharma, Inc.
Shreveport, LA
$20,000 target · $1,235,000 maximum
via StartEngine Primary, LLC
Not reported on this formsigner name on this filing (Ross Pryor Barrett) + listed as a related person on Form D filings of the same issuer (CIK 1429819) · 85%
EDGAR ↗Sep 30, 2025
File 020-36429
Regulation Crowdfunding offering (Form C)
Offering filed · deadline Dec 29, 2025
Calosyn Pharma, Inc.
Shreveport, LA
$20,000 target · $1,235,000 maximum
via StartEngine Primary, LLC
Not reported on this formsigner name on this filing (Ross Pryor Barrett) + listed as a related person on Form D filings of the same issuer (CIK 1429819) · 85%

Amounts are as reported by the issuer on the form; Regulation Crowdfunding forms report a target and maximum, not sales. Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Ross Barrett by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 11 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Ross Barrett is listed on, as found in their SEC filings (Form C, Reg A, Form ADV, EDGAR profile) or on the sponsor's own site; none belongs to the person unless the sponsor's site says so. Checked Oct 24, 2026.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Houston, TX). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Found on the sponsor's own site

calosyn.com ↗ found on CALOSYN PHARMA, INC. (calosyn.com — Form C 0001429819-26-000001 (issuer website as filed))

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Louisiana state courts — find the court ↗Massachusetts MassCourts ↗Georgia state courts — find the court ↗Colorado state courts — find the court ↗Texas re:SearchTX court records ↗Hillsborough County FL Clerk (HOVER) ↗Miami-Dade Clerk online case search ↗California — find the county court ↗Los Angeles Superior Court case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Louisiana Secretary of State business search ↗Massachusetts Secretary of State business search ↗Georgia Secretary of State business search ↗Colorado Secretary of State business search ↗Texas Secretary of State business search ↗Florida Secretary of State business search ↗California Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Ross Barrett appears on a new Form D, or when a court case or SEC action is matched to them. See plans →